Mayzent Interactions
There are 730 drugs known to interact with Mayzent (siponimod), along with 8 disease interactions. Of the total drug interactions, 577 are major, 143 are moderate, and 10 are minor.
- View all 730 medications that may interact with Mayzent
- View Mayzent disease interactions (8)
Most frequently checked interactions
View interaction reports for Mayzent (siponimod) and the medicines listed below.
- amlodipine
- Ampyra (dalfampridine)
- armodafinil
- aspirin
- atorvastatin
- baclofen
- bupropion
- Copaxone (glatiramer)
- cyclobenzaprine
- Cymbalta (duloxetine)
- dalfampridine
- duloxetine
- Emgality (galcanezumab)
- escitalopram
- Evrysdi (risdiplam)
- gabapentin
- hydrochlorothiazide
- lamotrigine
- levothyroxine
- Lyrica (pregabalin)
- magnesium oxide
- methotrexate
- modafinil
- Ocrevus (ocrelizumab)
- omeprazole
- oxybutynin
- pantoprazole
- Tecfidera (dimethyl fumarate)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Mayzent disease interactions
There are 8 disease interactions with Mayzent (siponimod) which include:
- cardiovascular disease
- encephalopathy
- MS
- malignancies
- infections
- liver disease
- macular edema
- vaccinations
More about Mayzent (siponimod)
- Mayzent consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Imprints, shape & color data
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.